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Immunoassays areanalytical methodsthatdetectinteractions betweenantibodiesandantigens. Immunoassays were
usedoriginaHly todetectlargebiologicalmolecules. The newgenerationoftheseantibody-based assays candetectsmall
syntheticcompounds. As aresult, immunoassays arebeingdeveopedspecificallyforbionmrkersofexposureandeffect
toewninmentaly pevalentchmlahsImmn ical detctionofparentcompoudsinboodandtisues,metabolites
inexcreta, andadductswithDNAandprotein havebeen successfulyperformedby sveral in tors. Althoughthere
isgreatpotentialfor useof immunoays inbiologicalmonitoringstudies,the limitationsoftheseanalysesmustbeful-
lyundentoodtoprevent improperevaluationofthe acquireddata. Thisreviewwillcoversomeofthebackgroundmaterial
necessary tounderstand how anantibody-based assay isdeveloped. The differencesbetweenpolyclonalandmonoclonal
antibody-basedassaysandtheimportanceofantibodyclass, affinity, specificity, andcross-reactivitymustbeconsidered
in both study design anddataanalysis.
Biological Monitoring
Biologicalmonitoring isusedto measuretheabsorbeddoseof
a chemical following an exposure. It is an important measure-
ment sinceonly the internalized chemical isbioavailable to in-
teract with the biological system. The monitoring measures
either apharmacokinetic orpharmacodynamic variable. Phar-
macokinetic variables arebiomarkers ofexposure. Thepatho-
logicalchangecausedby achemical onthebiological system is
apharmacodynamiceffect. Mostoftenmonitoringhasmeasured
pharmacokinetic variables such as the concentrations of the
parent chemical or its metabolites in blood, tissue, expired
breath, andexcretory levels following an exposure. Mostphar-
macodynamic variables arebiomarkersofeffect. Forexample,
decrease in blood pseudocholinesterase activity following ex-
posure to organophosphate pesticides is a pharmacodynamic
effect.
Somechemicalcompounds ortheirmetabolites arecapableof
covalently binding to biological molecules such as DNA and
proteins to formadducts intargetandperipheral tissues. Many
oftheseadduct-formingcompoundshavealsobeenshowntobe
carcinogenic. Although the measurement of adducts in peri-
pheral tissues has often been found to be proportional to
external exposure, no correlation between the adduction and
tissue-specific cancershas everbeenproven. Themeasurement
of blood component adducts (hemoglobin, albumin, and
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lymphocyteDNA) as amethodofbiologicalmonitoringis cur-
rentlybeinginvestigated(Table 1)sincetheseadducts areimpor-
tant asbiomarkersofexposure. Immunoassays arewellsuited to
detectbiomarkers ofexposure.
Immunoassays
"Immunoassay" is ageneric termfor anymethodthatdetects
the interaction between an antibody and an antigenic analyte.
This interaction can be used to identify, localize, purify, and
quantitatetheanalyte. Originally, inimunoassays weredeveloped
to detect macromolecular aggregates, such as bacteria and
viruses. Detectionofsmallmolecularweightcompounds(drugs,
TIble 1. Immunoassays inbiomonitoring.
Exposure Biomarker' Location Year Reference
Cokeovens BaP-DNA Netherlands 1990 (16)
Roofing BaP-DNA U.S. 1985 (12)
Firefighters BaP-DNA U.S. 1989 (14)
Barbecue meat BaP-DNA U.S. 1989 (14)
Dietary NNO-DNA China 1986 (4)
Dietary AFB,-SA China 1988 (11)
AFB, inurine Philipines 1986 (4)
DDT DDA inurine India 1987 (5)
Cigarette smoke ORP inurine U.S. 1985 (6)
ORP in serum U.S. 1988 (7)
Ethyleneoxide 2-hydroxyethyl-Hb Europe 1988 (10)
Cokeovens anti-BaP-DNA Ab U.S. 1985 (8)
Phthalic anhydride anti-PH-SA Ab U.S. 1987 (9)
'BaP, benzo[alpyrene adducts; NNO-DNA, N-nitrosamine-DNA adducts;
AFB,-SA, aflatoxin BI-serum albumin adducts; AFB,, aflatoxin B,; DDA,
1,1,1-trichloro-2,2 bis(p-chlorophenyl)acetic acid; ORP, oncogene-related pro-
tein;2-hydroxyethyl-Hb, hydroxyethyl-hemoglobinadducts;anti-BaP-DNAAb,
anti-benzo[a]pyrene-DNA adduct antibodies in serum; anti-PH-SA Ab, anti-
phthalicanhydride-serum albuminadductantibodies in serum.ROSNERETAL
industrial chemicals, etc.) by immunoassay has been used for
about35 yearsandwasinitiatedin 1917(1). Immunoassays are
now being developed to detect environmental contaminants
foundintheexcretaandtissuesasparentchemical,metabolites,
andadducts(Table 1). Themajoradvantagesoftheimmunoassay
method for performing this environmental biomonitoring are
sensitivity, specificity for the analyte, simplicity and speed of
analyses formultiple samples, andeaseofstandardization.
ImmunochemistryDefliitions
Antigens are substances that are recognized by the immune
systemasforeigntothehostandinduceanimmuneresponse. An
immuneresponsemayormaynotinvolvetheproductionofsolu-
bleantibodies(someimmuneresponsesarecellmediated). The
partofthe antigen to which theantibody binds istheantigenic
determinantorepitope. Antigenshavemanydifferentpotential
determinants, such as variousportions ofabacterial cell wall.
Antibodies areaclass ofproteins thatareinduced following
introductionofanantigen. Becausetheseproteinsarefoundin
the gamma globulin fraction of serum, the term "immuno-
globulins" (Ig) is synonymous for antibodies. There are five
mainclassesofantibodies: IgG, IgM,IgA, IgD, andIgE. IgGis
themajorclassofserumimmunoglobulins. IgGantibodieshave
a molecular weight ofabout 150,000 and possess fourpeptide
chains: twoidenticalheavychains (MW50,000) andtwo iden-
ticallightchains(MW25,000). IgMisthefirstclassofantibody
produced during theprimary response. It is apentamer ofthe
basicIgGantibody structure, whichitselfcontainstwocombin-
ingsites, orparatopes. Theseparatopesarethesitesofantibody
interaction with the antigen and are of equal affinity and
specificity forthedeterminantoftheantigen. Thisregionofthe
immunoglobulin molecule is calledthevariableregion.
IgG constitutes most ofthe secondary response toantigens.
Becauseofthis, mostimmunoassaysuseIgGantibodies. IgMhas
tenidenticalvariableregions. Immunologistsestimatethatover
11 millionvariableregionsarepossible(2). Thisdiversityisex-
ploited in antigen-directed immunoassays by preparing an-
tibodies withthedesiredparatope.
Haptensarechemicalsthatcanbindtoaregionoftheparatope
ofanantibody butcannotelicitanantibody responseby them-
selves. Haptensusually havemolecularweights less than 1000
(3). Thesesmallmolecules canbecoupled tolargermolecules
(carriers)toyieldsyntheticantigens. Theelicitedantibodiesmay
recognize thehapten aspartoftheepitope.
AntibodyPreparation
Theprocessofeliciting,purifying, andcharacterizing ananti-
body for an immunoassay is expensive and time consuming.
Animals arefirstimmunizedwiththetargetantigen orhapten-
carriermolecule. Ifantibody levels (titers) inthe sera arehigh
withtheappropriatespecificity fortheantigen, theneitherthe
sera orantibody-producing cells areisolated.
Normally an organism has only a small population of an-
tibodieswithagivenvariableregion. Followingimmunization,
thereis ariseinthe serumtiterofantibodies thatrecognize the
injected antigen. Antigen-recognizing antibody is elicited as
follows. Specialized cells located in the speen, called B-
lymphocytes, display antibody on their surface membrane.
When antigen binds to the membrane-bound antibody, the B-
lymphocyteissimulatedtoeitherdivideintoidenticaldaughter
cellsormatureintoaplasmacellthatiscapableofsecretinganti-
bodyintotheserum. Thedaughtercellsfollowthesamepattern
whenanantigenbindstotheirsurfaceantibody. Theantibodies
producedby agiven B-lymphocyte andall itsprogeny possess
identicalparatopesandsoaremonoclonal. Antibodiesfromdif-
ferentB-lymphocyteparentcells arepolyclonal.
Pblyclonalantibodiescanbepreparedquiteeasilybypurify-
ingtheseraofimmuniz aimals. Thispolyclonalseracontains
manydifferentantibodiesincludingoneormorewithaffinityfor
thedesiredanalyte. Functionally, thisisoftennotaproblemsince
oneparatopewith ahighaffinity fortheantigen willdominate
theobservedbindingcharacteristics. Monoclonalantibodiesof-
ferthepossibility ofisolatingarareantibody inthepolyclonal
mixturethatbindstoahaptenwithhighaffinity. Preparationof
monoclonalantibodiesismoreinvolvedthanthatofpolyclonal
antibodies. TheB-lymphocytes areisolatedfromthe spleenof
an immunized animal. These mortal cells arethenchemically
fused with an immortal, established myeloma cell line. The
resultinghybridcells(hybridomas) retainthecharacteristicsof
producing antibody and immortality. The hybridomas are
isolatedasindividualcellsandgrowninculture. Allthedaughter
cells will producemonoclonal antibodies that may be isolated
fromtheculturemediumorfromascitesfluidafterinjectionof
thehybridomas into ahostanimal.
Aftertheantibodiesareprepared, theycanbeusedinawide
varietyofimmunoassa formats. Mostschemeshavetheanalyte-
directedantibodywithamarkeroralabeledsecondantibodythat
recognizes the analyte-directed antibody. The label or marker
provides thebasis forquantification.
DevelopmentofImmunoassays
There are four major stages in the development of an im-
munoassay: antibody production, antibody characterization,
method validation, and final field studies. This entireprocess
maytakeseveralmonthstoyearstocomplete. Therequirements
oftheanalyses should determinetheneed formaking amono-
clonal or polyclonal antibody. Production of antibodies was
previously discussed.
Characterizationincludesevaluationofthespecificityandaf-
finityoftheantibody. Theclassoftheantibody shouldalsobe
determined since polymeric immunoglobins (IgM) can com-
plicatetheanalyses. Thecross-reactivityforsimilarantigensor
chemical structures shouldbedeterminedandreported. Often,
similarchemicalcompoundswillexhibitmeasurablebindingto
the sameantibody. Ifthesestructurally similarcompounds are
present in test substances, the qualitative and quantitative
analysiswillbeaffected. Ifusinganimmunoassaypreparedcom-
merciallyorbyanotherinvestigator, itiscriticaltofullyunder-
standthelimitationsoftheantibody. Thefinalimmunoassay can
only be as good as the antibody with regard to sensitivity and
specificity. Oncetheantibody hasbeencharacterizedfully, dif-
ferent formats of immunoassay should be tested for the best
specificity, sensitivity, andreproducibility.
Methodsvalidationfortheimmunoassayrequiresdetermina-
tionofthelinearrangeforanalyses, recoverystudiesusingstan-
dards, and correlationwith otherchemical methods.
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Use ofImmunoassay toDetectBiomarkers
Several factors must be considered to determine ifdevelop-
mentoruseofanimmunoassay isappropriate forafield study.
The use of a specific antibody-based assay requires that the
identity ofthe exposure agent(s) is known. Chemical analyses
shouldbeemployedtomeasureweaklytoxicagentsthatonlyre-
quire detection at high levels. Compounds that can be easily
detectedby moreclassical means rarely warrant immunoassay
development unless a less expensive screening method is
desired. Animmunoassay shouldnotbedevelopedforanagent
thatwillonlybestudiedafewtimesduetotheconsiderablecost
ofdevelopment.
There are several circumstances that are ideal for using im-
munoassays. Agentsthatareamajorpublichealthconcernthat
willrequirerepetitivestudiesjustifytheexpenseofresourcesto
developtheantibody. Agentsthatrequirelowlimitsofdetection
that cannot be obtained by classical chemical analyses and
samples that require excessive preparation due to matrix in-
terference are ideal situations for immunoassay use. However,
oneshouldbecautionedthatimmunoassayscanalsobegreatly
affected by matrix interferences. Immunoassay analyses are
recommended forsituations thatrequirequickturnaroundoras
ascreeningtesttoguidefuturestudies. Antibody-basedanalyses
are becoming more prevalent in places where complicated
chemicalanalyses arenotfeasible, suchasThirdWorldnations
(4,5,11).
Severalbiologicalmonitoring studieshavebeenperformedby
various investigators using immunoassay for detecting
biomarkers (Table 1.) Inthese studies, biomarkersofexposure
(urinary metabolites and macromolecular adducts) and bio-
markersofeffect(oncogene-relatedproteins)wereallmeasured.
Animmunoassay capableofdetectingaflatoxinB1 wasusedto
comparetheamountsfoundintheurineofPhilippineandFrench
residents (4). ThePhilippine residentshad 13timeshigherlevels
than the residents ofFrance. This was probably due to higher
levels ofcontamination inPhilippine foodstuffs.
Sometimes it is more appropriate for the immunoassay to
detectanimportantmetaboliteratherthantheparentcompound.
Thelipid-solublepesticideisnotreadilyexcretedfromthebody.
ThemajorurinarymetaboliteofDDTistheaceticacidderivative
ofthe parent, DDA. An immunoassay was developed in India
that can beperfomed oncrudeurinewithoutextensive sample
preparation (3).
Immunoassayshavebeenusedtodetectproteinscodedbyon-
cogenes. Thefunctionoftheseproteinproductsisnotknown, but
their presence signals that the oncogenes have been activated.
Oncogeneactivationisusuallyaresultofretroviralinfection, but
some chemical carcinogens may also turn on these genes (6).
Theoncogene-relatedproteinswerefoundtobeassociatedwith
smoking (7).
A variation of immunoassay can be used to detect the im-
munologic response rather than a chemical antigen. The
presenceofmacromoleculeadductscancausethebody tomount
anantibody responsetothealteredbiomolecules. Ahightiterof
antibodies to the alteredbiomolecules in theexposedperson's
serum is evidenceofthe formation ofadducts.
Immunoassays to detect adduction in a wide variety of
macromoleculeshavebeensuccessful. Antibodiesthatrecognize
benzo[a]pyrene-modified DNA have been found in coke oven
workers (8); antibodies that recognize phthalic anhydride-
modified albumin have been detected in chemical production
workers(9). Hospitalworkersthatuseethyleneoxidesteriliza-
tion havebeen showntohave increased2-hydroxyethyl-hemo-
globinadductlevelswhencomparedtootherhospitalemployees
(JO). Aflatoxin serumalbuminadductswere foundtocorrelate
wellwithurinarymetabolitesinChinesepeoplethathadalarge
dietary intake ofaflatoxins from their corn consumption (11).
DNA adducts of N-nitrosamines and polycyclic aromatic
hydrocarbons have been analyzed by immunoassays. Ben-
zo[a]pyrene-DNAadductsweremeasuredinthelymphocytesof
roofers(12), foundry(13)andcokeovenworkers(8), firefighters
(14), smokers (15), and following consumption ofbarbequed
meat (14).
Summary
Immunochemical analyses ofbiomarkers of exposure have
beensuccessfullydevelopedbyseveralinvestigators. Although
thereisgreatpotentialforuseofimmunoassays msuchbiological
monitoringstudies, thelimitationsofthesemethodsmustbefully
understoodtopreventimproperevaluationoftheacquireddata.
Thedifferencesbetweenpolyclonal andmonoclonalantibody-
based assays and the importance of antibody class, affinity,
specificity, andcross-reactivitymustbeconsideredinthestudy
designandthedataanalysis.
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